The DOI matches its Crossref record; 410 of the 410 references it cites were found in a registry or an index.
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–410 of 410
Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?
Drummond, M. W., & Holyoake, T. L. (2001) · Blood Reviews · doi:10.1054/blre.2001.0152 · Cited by 20
Laethem, J. V. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09525.x · Cited by 19
Matsumoto, J., Kaneda, M., Tada, M., Hamada, J., Okushiba, S., Kondo, S., Katoh, H., & Moriuchi, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01240.x · Cited by 17
Cancer genome targets: RAF-ing up tumor cells to overcome oncogene addiction
Workman, P. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.6.611 · Cited by 16
Apoptosis regulating proteins as targets of therapy for haematological malignancies
Kornblau, S. M., Konopleva, M., & Andreeff, M. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.2027 · Cited by 16
Inositide signalling in Chlamydomonas: characterization of a phosphatidylinositol 3-kinase gene
Molendijk, A. J., & Irvine, R. F. (1998) · Plant Molecular Biology · doi:10.1023/a:1005973423723 · Cited by 15
Wang, X. Y., & McCubrey, J. A. (1996) · PubMed · Cited by 15
Self-citationKi-ras and the Characteristics of Mouse Lung Tumors
Ramakrishna, G., Bialkowska, A., Perella, C. M., Birely, L., Fornwald, L. W., Diwan, B. A., Shiao, Y., & Anderson, L. M. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200007)28:3<156::aid-mc4>3.0.co;2-m · Cited by 14
Dynamin inhibits phosphatidylinositol 3-kinase in hematopoietic cells
Harrison-Findik, D. D., Misra, S., Jain, S. K., Keeler, M. L., Powell, K. A., Malladi, C. S., Varticovski, L., & Robinson, P. J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00130-0 · Cited by 11
Bcr in Vascular Smooth Muscle Cells: Involvement of Ras and Raf‐1 Activation by Bcr
Abe, J., Che, W., Yoshizumi, M., Huang, Q., GLASSMAN, M., OHTA, S., Wu, Y., Arlinghaus, R. B., & Berk, B. C. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03959.x · Cited by 6
Cited by
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Self-citationMechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
FDA-approved small-molecule kinase inhibitors
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,013
The role of IL-6 and STAT3 in inflammation and cancer
Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 950
Hochhaus, A., O'Brien, S. G., Guilhot, F., Druker, B. J., Branford, S., Foroni, L., Goldman, J. M., Müller, M. C., Radich, J. P., Rudoltz, M., et al. (2009) · Leukemia · doi:10.1038/leu.2009.38 · Cited by 856
Metadata
- Authors
- Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A.
- Venue
- Leukemia
- Published
- 2004-01-22
- Volume
- 18
- Issue
- 2
- Pages
- 189-218
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1529003705
- Cited by
- 684
- References
- 410
- FWCI
- 22.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.